First Time in Human Study of Intravenous Interleukin-18 Antibody

Clinical trial NCT01035645 · COMPLETED

Trial details

NCT number: NCT01035645
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Inflammatory Bowel Diseases

Start date: 2010-01-05
Primary completion: 2012-07-11
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.